Cancer

The businessman, philanthropist and long-standing Cancer Research UK supporter tells us about his family’s latest £1.2m donation. At first glance, Cancer Research UK might not seem the obvious charity of choice for a family of philanthropists historically committed to supporting education. Until recently, their many beneficiaries chiefly comprised universities, libraries and schools. But for David
0 Comments
June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Marlys. It was the sunny month of July. We were sharing a vacation rental with our daughter, son-in-law, and the grandkids in a nearby mountain village. My husband’s cancer was
0 Comments
Screening tests mark a turning point in early detection of cancers. The first screening test widely used to detect cancer, developed by George Papanicolaou, was the Pap test. Although Papanicolaou presented his findings in 1923, it wasn’t until the early 1960s, when the Pap test was backed by the American Cancer Society (ACS), that doctors
0 Comments
Lung adenocarcinoma cells, a type of non small cell lung cancer (NSCLC) One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO)
0 Comments
Breast cancer is essentially incapable of taking a life as long as it stays in a person’s breasts and doesn’t spread to other areas of the body. When it metastasizes to important organs like the liver, lungs, bones, or brain, however, it can have disastrous consequences. Therefore, it’s important that breast cancer research emphasizes understanding
0 Comments
Prostate cancer cells. Prostate cancer cells viewed under a microscope. Men with advanced, hormone-sensitive prostate cancer will now have another treatment option in England, following the approval of the hormone therapy enzalutamide (Xtandi). The National Institute of Health and Care Excellence (NICE) has approved the combination of enzalutamide and androgen deprivation therapy (ADT) for adults
0 Comments
June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Erin. 37-Year-Old Cancer Survivor and Mom of Four Shares Her Survival Story to Help Others An advanced Stage III colon cancer diagnosis was the last thing I expected to receive
0 Comments
A patient website that supports cancer patients and their family caregivers Confronting a cancer diagnosis is one of the most demanding, isolating things you can do. Family and friends are an amazing source of support, but constantly sharing updates with each and every one of them is impractical. So what resources are available to families
0 Comments
Our partnership with ScottishPower began in 2012, since then it’s raised over £30m. We’re thrilled to announce that we’re extending this extraordinary partnership for another three years. This means that the incredible employees, suppliers and customers of ScottishPower will continue to help us fund our life-saving research until 31 March 2024. Alongside their creative fundraising
0 Comments
May is Mental Health Awareness Month. Over the next few weeks, OncoLink will feature blogs about common mental health challenges faced by cancer patients, caregivers, and healthcare professionals. Please remember, if you are in crisis, help is available. National Suicide Prevention Lifeline 800-273-8255 National Alliance on Mental Health (NAMI) Helpline 800-950-6264 A caregiver is someone
0 Comments
Cancer treatments carry with them plenty of side effects, including gastrointestinal issues. Diarrhea and constipation are especially common. These can make treatment all the more unpleasant and even cause lingering issues. However, a new study may have found a way to protect gut health from chemotherapy. Researchers at Northwestern University tested how certain types of
0 Comments
Achilles Therapeutics has been listed and is open to public investment on the world’s second largest stock exchange Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million to invest in the development of new cancer immunotherapies through the closing of its initial public offering (IPO). This milestone marks the ‘birth’ of a
0 Comments